Transplant

Percentage of Cardiac Transplant Patients who had Osteoporosis Screening by DXA Scan (2001, 2015-2020)

Percentage of Cardiac Transplant Patients who had Osteoporosis Screening by DXA Scan (2001, 2015-2020)

2001, 2015-2020

DXA = dual-energy X-ray absorptiometry

Glucocorticoid use is associated with bone loss and fractures. The 2017 American College of Rheumatology guidelines on glucocorticoid-induced osteoporosis recommend a dual-energy X-ray absorptiometry (DXA) scan for patients on glucocorticoid therapy for 3 months or more. Cardiac transplant recipients receive glucocorticoids for more than 3 months after surgery to prevent organ rejection. Fewer than 15% of transplant patients had DXA scans before or within 6 months after transplant in 2001. Collaboration between the Transplant and Osteoporosis Centers since 2001 has markedly improved the frequency of DXA scans in cardiac transplant patients before or within 6 months after transplant surgery. Between 74% and 95% of cardiac transplant patients since 2015 have had bone evaluation with DXA scan.